Arrowadvantages Pressure Injectable Peripherally Inscrted Central Catheter Kits
510(k) K113277
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK113277 | Date21 Jun 2012 | StatusActive |
Recalls
-
- Ongoing Z-2378-2026
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
-
- Terminated Z-1254-2020
Product lidstock contains the incorrect expiration date for the product
-
- Terminated Z-2023-2018
Product sterility may be compromised due to unsealed packaging.
-
- Terminated Z-0602-2018
Finished good kits may contain incorrect components. Kits that should contain a 5 FR 2 lumen catheter may contain a 4 FR single lumen catheter and kits that should contain a 4 FR single lumen catheter may contain a 5 FR 2 lumen catheter. This may cause a delay in treatment while a replacement catheter is obtained.
-
- Terminated Z-0182-2018
There is a possibility that the finished good kits may contain 5 Fr peel-away sheaths instead of the required 4 Fr peel-away sheaths.
-
- Terminated Z-0207-2016
Possibility that the catheter peel-away component hub tabs may prematurely detach when the practitioner begins to peel apart the sheath body from the catheter. Although the issue does not pose a significant risk to the patient, it may cause a delay of treatment when placing the catheter.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LJS
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5970
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent